* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Wednesday, July 23, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Black Box Players presents ‘The Three Musketeers’ – CBS 19 News

    Experience the Adventure: Black Box Players Bring ‘The Three Musketeers’ to Life!

    AP Entertainment SummaryBrief at 1:51 p.m. EDT – Channel 3000

    Entertainment Highlights: Key Updates You Can’t Miss

    ‘Devil Wears Prada 2’ casts Anne Hathaway’s love interest replacing Adrian Grenier’s Nate – Entertainment Weekly

    Devil Wears Prada 2′ Casts New Love Interest for Anne Hathaway, Replacing Adrian Grenier’s Nate

    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Morgan Adamski Joins PwC in Newly Created Cyber, Data & Technology Risk Division – HSToday

    Morgan Adamski Leads the Charge in PwC’s Cutting-Edge Cyber, Data & Technology Risk Division

    Transformative technology, support for food entrepreneurs spotlighted – University of Hawaii System

    How Cutting-Edge Technology and Strong Support Are Revolutionizing Food Entrepreneurs’ Success

    Cold Weather Alloy Opens New Possibilities for Space Technology – Universe Today

    Revolutionary Cold Weather Alloy Unlocks New Frontiers in Space Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Black Box Players presents ‘The Three Musketeers’ – CBS 19 News

    Experience the Adventure: Black Box Players Bring ‘The Three Musketeers’ to Life!

    AP Entertainment SummaryBrief at 1:51 p.m. EDT – Channel 3000

    Entertainment Highlights: Key Updates You Can’t Miss

    ‘Devil Wears Prada 2’ casts Anne Hathaway’s love interest replacing Adrian Grenier’s Nate – Entertainment Weekly

    Devil Wears Prada 2′ Casts New Love Interest for Anne Hathaway, Replacing Adrian Grenier’s Nate

    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Morgan Adamski Joins PwC in Newly Created Cyber, Data & Technology Risk Division – HSToday

    Morgan Adamski Leads the Charge in PwC’s Cutting-Edge Cyber, Data & Technology Risk Division

    Transformative technology, support for food entrepreneurs spotlighted – University of Hawaii System

    How Cutting-Edge Technology and Strong Support Are Revolutionizing Food Entrepreneurs’ Success

    Cold Weather Alloy Opens New Possibilities for Space Technology – Universe Today

    Revolutionary Cold Weather Alloy Unlocks New Frontiers in Space Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Ozanimod Controls MS Disease Activity Regardless of Age

March 4, 2024
in Health
Ozanimod Controls MS Disease Activity Regardless of Age
Share on FacebookShare on Twitter

WEST PALM BEACH, Fla. — Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod (Zeposia).

“Regardless of age category, the adjusted annualized relapse rate was below 0.2 in the phase III parent trials and remained low in the DAYBREAK open-label extension in patients treated with continuous ozanimod,” said Jeffrey Cohen, MD, of the Cleveland Clinic in Ohio, in a poster presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum.

A total of 2,257 RMS patients in the parent SUNBEAM and RADIANCE trials participated in the open-label DAYBREAK extension study. By age category, the number of patients treated continuously with 0.92 mg ozanimod from the start of the phase III trials included 118 people ages 25 or younger, 268 people ages 26 to 35, 313 people ages 36 to 50, and 62 people ages 50 and older.

Patients continually taking ozanimod, an oral sphingosine 1-phosphate (S1P) receptor 1 and 5 modulator, had consistently lower rates of relapse and almost always had numerically lower rates of relapse than those who originally received interferon beta-1a before being switched to ozanimod, Cohen said.

“We also noted that even the patients who started the trial on interferon, when they switched to ozanimod in the open-label extension, they basically caught up to the people who were on ozanimod the entire length of the phase III trials and the extension,” he told MedPage Today.

There were similar relationships on age for the number of gadolinium-enhancing lesions, which averaged 0.6 per scan throughout the open-label extension, Cohen added. The number of new or enlarging T2 lesions per scan was reduced as patients got older, he said.

“This is something that has been observed in relapsing multiple sclerosis over time,” Cohen noted. A decline in these lesions may be part of declining immune activity as people age, he suggested. Long-term treatment also may interrupt the cascade of molecular inflammatory events that can cause nerve injury, he noted.

Ozanimod was approved to treat RMS in 2020 based on data from the pivotal SUNBEAM and RADIANCE studies, which showed lower relapse rates with ozanimod compared with interferon beta-1a. Patients who completed SUNBEAM and RADIANCE were eligible to enroll in the open-label extension of ozanimod 0.92 mg.

Cohen explained that while the relapses and appearance of new lesions remained low overall in the extension study, the team wanted to determine whether those rates diminished with age.

The findings should be reassuring to clinicians who are treating older patients with ozanimod for long durations, noted Patrick Vermersch, MD, PhD, of University Hospital Lille in France, who wasn’t involved with the study.

“When you treat long-term with these immune-modulating agents, there is always a concern that the risk of infections can occur, and the risk would be greater in an older patient,” Vermersch told MedPage Today. “We did not see this occur in patients in the DAYBREAK study.”

In a companion study presented at the meeting, Cohen and colleagues reported that the final analysis of the DAYBREAK extension study showed that treatment with 0.92 mg ozanimod controlled disease activity for longer than previously reported — a mean of 60.9 months, with some patients having been on treatment for 117.2 months (i.e., nearly 10 years).

“Ozanimod was generally well tolerated, with 78.2% of participants completing the study,” Cohen said. “Ozanimod demonstrated sustained efficacy with a low annualized relapse rate of 0.098, low numbers of new or enlarging T2 lesions of an average of less than 1 new or enlarging lesion per scan at 60 months, and mean number of gadolinium-enhancing lesions on brain MRI of an average of about 0.24 lesions per scan at 60 months.”

The safety findings were consistent with phase III trials and the established safety profile of ozanimod, Cohen noted.

“While we rarely would start a patient on interferons or glatiramer acetate these days but rather on disease-modifying agents, it is still good that we have this data to show there is an advantage to the use of these newer agents such as ozanimod,” he said.

author['full_name']

Ed Susman is a freelance medical writer based in Fort Pierce, Florida, USA.

Disclosures

The ozanimod studies were sponsored by Bristol Myers Squibb.

Cohen disclosed financial relationships with Astoria, Bristol Myers Squibb, Convelo, EMD Serono, Find Therapeutics, INmune, and Sandoz.

Vermersch disclosed relationships with Bristol-Myers Squibb, Novartis, Merck, EMD Serono, Biogen, and Sanofi.

Primary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Cree BAC, et al “Long-term efficacy of the sphingosine 1-phosphate receptor modulator ozanimod by age category in patients with relapsing multiple sclerosis: final results from two phase 3 trials and an open-label extension trial” ACTRIMS Forum 2024; poster P091.

Secondary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Selmaj KW, et al “Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: final analysis of the DAYBREAK open-label extension study” ACTRIMS Forum 2024; poster P090.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/actrims/108994

Tags: ControlshealthOzanimod
Previous Post

“I Have the Unfortunate Genetics That I Am Bald”: What We Heard This Week

Next Post

School Shootings in U.S. Reach Highest Recorded Levels

Equity LifeStyle Properties Inc reports results for the quarter ended June 30 – Earnings Summary – TradingView

Equity LifeStyle Properties Inc Reports Impressive Q2 Earnings for June 30

July 23, 2025
The Ukraine war will shape the world – Financial Times

How the Ukraine War Is Shaping the Future of Our World

July 23, 2025
7 of the Best Freebies You Can Get in Economy—Meals, Alcoholic Drinks, and Toys Included – Yahoo Home

7 of the Best Freebies You Can Get in Economy—Meals, Alcoholic Drinks, and Toys Included – Yahoo Home

July 23, 2025
Black Box Players presents ‘The Three Musketeers’ – CBS 19 News

Experience the Adventure: Black Box Players Bring ‘The Three Musketeers’ to Life!

July 23, 2025
Opinion | U.S. Global Health Aid Is an Exemplar of Efficiency – The Wall Street Journal

How U.S. Global Health Aid Leads the Way in Efficiency and Impact

July 23, 2025
Politics at play? Jagdeep Dhankhar’s ‘shock’ exit as VP turns critics into ‘well-wishers’; Congress seeks – Times of India

Jagdeep Dhankhar’s Stunning Vice Presidential Exit Wins Over Critics, Sparks Congress Reaction

July 23, 2025
Morgan Adamski Joins PwC in Newly Created Cyber, Data & Technology Risk Division – HSToday

Morgan Adamski Leads the Charge in PwC’s Cutting-Edge Cyber, Data & Technology Risk Division

July 23, 2025
Women’s Gymnastics All Sports Schedule 2025 – Mountain West Conference

2025 Women’s Gymnastics Schedule: Can’t-Miss Matchups in the Mountain West Conference

July 23, 2025
Fyodor Konyukhov sets off on an ecological expedition across three oceans – realnoevremya.com

Fyodor Konyukhov sets off on an ecological expedition across three oceans – realnoevremya.com

July 22, 2025
‘A disaster for all of us’: US scientists describe impact of Trump cuts – theguardian.com

A Disaster for All of Us’: How Trump’s Cuts Devastated US Science

July 22, 2025

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (734)
  • Economy (758)
  • Entertainment (21,642)
  • General (16,053)
  • Health (9,796)
  • Lifestyle (766)
  • News (22,149)
  • People (759)
  • Politics (767)
  • Science (15,974)
  • Sports (21,255)
  • Technology (15,740)
  • World (741)

Recent News

Equity LifeStyle Properties Inc reports results for the quarter ended June 30 – Earnings Summary – TradingView

Equity LifeStyle Properties Inc Reports Impressive Q2 Earnings for June 30

July 23, 2025
The Ukraine war will shape the world – Financial Times

How the Ukraine War Is Shaping the Future of Our World

July 23, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version